RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

Search

CNO Financial Group Inc

Abierto

SectorFinanzas

41.53 2.9

Resumen

Variación precio

24h

Actual

Mínimo

40.07

Máximo

41.52

Métricas clave

By Trading Economics

Ingresos

70M

93M

Ventas

-46M

1.1B

P/B

Media del Sector

17.171

55.155

BPA

1.47

Rentabilidad por dividendo

1.69

Margen de beneficios

8.127

Empleados

3,300

EBITDA

-8.3M

165M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+15.31% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.69%

4.95%

Próximas Ganancias

27 abr 2026

Fecha Próximo Dividendo

23 jun 2026

Próxima Fecha de Ex Dividendo

9 jun 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-361M

3.8B

Apertura anterior

38.63

Cierre anterior

41.53

Noticias sobre sentimiento de mercado

By Acuity

54%

46%

353 / 441 Clasificación en Finance

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

CNO Financial Group Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

CNO Financial Group Inc previsión

Precio Objetivo

By TipRanks

15.31% repunte

Estimación a 12 Meses

Media 46.33 USD  15.31%

Máximo 50 USD

Mínimo 43 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CNO Financial Group Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

3 ratings

1

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

37.56 / 38.01Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

353 / 441 Clasificación en Finanzas

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por encima de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CNO Financial Group Inc

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
help-icon Live chat